Sudeep Pharma

| Annual Financials | 2022 | 2024 | 2025 | TTM |
Revenue  | 350 | 465 | 511 | 0 |
| Expenses | 276 | 278 | 312 | 0 |
EBITDA  | 75 | 188 | 199 | 0 |
| Operating Profit % | 20 % | 40 % | 38 % | 0 % |
| Depreciation | 5 | 9 | 11 | 0 |
| Interest | 2 | 4 | 6 | 0 |
Profit Before Tax  | 69 | 175 | 183 | 0 |
| Tax | 18 | 42 | 44 | 0 |
| Net Profit | 50 | 133 | 139 | 0 |
| EPS in ₹ | 356.01 | 12.28 | 12.79 | 0.00 |
Above figures are in Rs. Crores | Balance Sheet | 2022 | 2024 | 2025 |
Total Assets  | 344 | 514 | 717 |
| Fixed Assets | 137 | 180 | 189 |
| Current Assets | 197 | 275 | 424 |
| Capital Work in Progress | 8 | 45 | 88 |
| Investments | 0 | 0 | 0 |
| Other Assets | 199 | 289 | 440 |
Total Liabilities  | 344 | 514 | 717 |
| Current Liabilities | 147 | 137 | 175 |
| Non Current Liabilities | 34 | 21 | 49 |
Total Equity  | 163 | 356 | 493 |
| Reserve & Surplus | 162 | 355 | 481 |
| Share Capital | 1 | 1 | 12 |
Above figures are in Rs. Crores | Cash Flow | 2020 | 2021 | 2022 | 2024 | 2025 |
| Net Cash Flow | -0 | 8 | 10 | 4 | 23 |
| Investing Activities | -23 | -40 | -38 | -49 | -79 |
| Operating Activities | 10 | 35 | -3 | 66 | 49 |
| Financing Activities | 12 | 13 | 51 | -13 | 53 |
Above figures are in Rs. Crores | % Holding | Jun 2025 |
| Promoter | 91.07 % |
| FIIs | 0.00 % |
| DIIs | 0.00 % |
| Government | 0.00 % |
| Public / Retail | 0.00 % |
| Others | 8.93 % |
| No of Share Holders | 16 |